These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Amiodarone: a new etiology of diffuse interstitial pneumopathy? Apropos of 2 personal cases and 10 cases from the literature]. Vergnon JM; Wiesendanger T; Bellemin JP; Brune J Rev Mal Respir; 1984; 1(1):43-50. PubMed ID: 6463349 [TBL] [Abstract][Full Text] [Related]
5. [Amiodarone: a new cause of hypersensitivity pneumopathy?]. Arlet P; Carré P; Bismuth JM; Larregain-Fournier D; Le Tallec Y Rev Pneumol Clin; 1984; 40(3):205-7. PubMed ID: 6463506 [TBL] [Abstract][Full Text] [Related]
6. [Pneumonitis induced by amiodarone]. Terra Filho M; Vargas FS; Cukier A; Teixeira LR; Pinto RM; Pileggi F Arq Bras Cardiol; 1989 Oct; 53(4):201-5. PubMed ID: 2483501 [TBL] [Abstract][Full Text] [Related]
7. [Lung changes in amiodarone therapy]. Prayer L; Hübsch P; Frank H Pneumologie; 1989 Nov; 43(11):673-5. PubMed ID: 2608645 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vivo pulmonary toxicity of amiodarone and des-oxo-amiodarone in the hamster. Rafeiro E; Leeder RG; Brien JF; Kabalka GW; Chatla N; Massey TE Toxicol Appl Pharmacol; 1994 Aug; 127(2):275-81. PubMed ID: 8048071 [TBL] [Abstract][Full Text] [Related]
11. [Pneumopathies caused by hypersensitivity to amiodarone and associated nephropathies. Study by alveolar lavage]. Caubarrère I; Bonan G; Venet A; Chebat J; Uzzan D; Gilbert J; Beaufils H Ann Med Interne (Paris); 1985; 136(4):311-5. PubMed ID: 4037586 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone toxicity: recurrence of interstitial pneumonitis after withdrawal of the drug. Parra O; Ruiz J; Ojanguren I; Navas JJ; Morera J Eur Respir J; 1989 Oct; 2(9):905-7. PubMed ID: 2806517 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary responses to amiodarone in hamsters: comparison of intratracheal and oral administrations. Blake TL; Reasor MJ Toxicol Appl Pharmacol; 1995 Apr; 131(2):325-31. PubMed ID: 7716773 [TBL] [Abstract][Full Text] [Related]
15. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity. Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009 [TBL] [Abstract][Full Text] [Related]
16. [Pneumonitis and pulmonary fibrosis due to amiodarone. Report of 2 cases with optic and electronic microscopy]. Lunardi W; Lopes EA; Kehde E; Vargas FS; Pereira Júnior W; Uip DE; Cukier A; Terra Filho M; Hernández EA; Duarte MI Arq Bras Cardiol; 1986 Jun; 46(6):415-9. PubMed ID: 3579634 [No Abstract] [Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
18. Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid. Wilson BD; Clarkson CE; Lippmann ML Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1110-4. PubMed ID: 2024822 [TBL] [Abstract][Full Text] [Related]